Open AccessLandscape of the Peripheral Immune Response Induced by Local Microwave Ablation in Patients with Breast Cancer
Author(s) -
Zhou Wenbin,
Yu Muxin,
Mao Xinrui,
Pan Hong,
Tang Xinyu,
Wang Ji,
Che Nan,
Xie Hui,
Ling Lijun,
Zhao Yi,
Liu Xiaoan,
Wang Cong,
Zhang Kai,
Qiu Wen,
Ding Qiang,
Wang Shui
Publication year - 2022
Publication title -
advanced science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.388
H-Index - 100
ISSN - 2198-3844
DOI - 10.1002/advs.202200033
Subject(s) - immune system , peripheral blood mononuclear cell , cd8 , cancer research , medicine , breast cancer , immunotherapy , t cell , antigen , immunology , cancer , biology , in vitro , biochemistry
Minimally invasive thermal therapies have been attempted in the treatment of breast cancer, and the immune response induced by these therapies has not been fully reported. A clinical trial is performed to determine the effect of microwave ablation (MWA) in the treatment of early‐stage breast cancer. The authors perform single‐cell RNA sequencing on peripheral blood mononuclear cells (PBMCs) from six patients before and after ablation. NK and CD8 + T cells are activated by MWA of breast cancer, with the increased inhibitory signature of CD8 + T cells but not dysfunctional. Enhanced co‐stimulatory signature of CD4 + T cells is observed and increased frequency of ICOS + CD4 + T cells after MWA is confirmed by flow cytometric analysis. After ablation, T‐cell clones expand with increased T‐cell receptor diversities. Activated antigen receptor‐mediated signaling pathways are found in B cells. Enhanced interactions between B cells and CD4 + T cells are found, indicating that B cells are important antigen‐presenting cells that initiate CD4 + T cells in MWA‐induced immune response. Blockade of CTLA‐4 or PD‐1 of post‐MWA PBMCs show higher T‐cell activity than that of pre‐MWA PBMCs. This study provide global characteristics of MWA‐induced systemic immune response and pave a way for the identification of potential targets to improve the immune response.